Targeted Therapies for Stage III Non-Small Cell Lung Cancer

Will the success seen for stage IV patients receiving targeted therapies translate into cure for stage III patients? Dr. Daniel Morgensztern of the Washington University School of Medicine talks about...

mostra más

Will the success seen for stage IV patients receiving targeted therapies translate into cure for stage III patients? Dr. Daniel Morgensztern of the Washington University School of Medicine talks about what research is ongoing to answer that question.

mostra menos

Comentarios

Inicia sesión para dejar un comentario

Información

Autor	cancerGRACE
Página web	-
Etiquetas	#cancer #cancergrace #cell #clinical #daniel #dr #grace #iii #lung #medicine #of #personalized #school #stage #survival #targeted #therapies #trials #university #washington